Calculating The Indirect Costs Of Adult Pneumococcal Disease And The Rate Of Return To The 13-Valent Pneumococcal Conjugate Vaccine (PCV13) In Older Adults, With An Application To Denmark
Abstract
Authors
JP Sevilla A Stawasz D Burnes PB Poulsen R Sato DE Bloom